Core Laboratories Inc. reported $519M of revenue over the trailing twelve months, +0.35% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $519M (to Q2 2026). Net income: $24M, trailing twelve months to Q2 2026. Free cash flow: $15M, trailing twelve months to Q2 2026. Operating margin: 9.0%, trailing twelve months to Q2 2026.

CLBCore Laboratories Inc.

Energy

$9.91-22% 1Y

$9.91

$9.3952 weeks$19.64

CLB as reported

Core Laboratories Inc. reported $519M of revenue over the trailing twelve months, +0.35% on the year before. 11 reported series are charted on this page, each one as filed.

$519M

Revenue, trailing twelve months · to Q2 2026 · +0.35% against the twelve months before

Net income: $24M
Net income · −18% year on year · trailing twelve months to Q2 2026
Free cash flow: $15M
Free cash flow · −64% year on year · trailing twelve months to Q2 2026
Operating margin: 9.0%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for CLB, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$519M	+0.35%	Q2 2026
Net income	$24M	−18%	Q2 2026
EPS	$0.52	−17%	Q2 2026
Gross margin	19%	n/a	Q2 2026
Operating margin	9.0%	n/a	Q2 2026
Net margin	4.6%	n/a	Q2 2026
ROE	11%	n/a	Q2 2026
ROA	4.9%	n/a	Q2 2026
ROIC	12%	n/a	Q2 2026
Free cash flow	$15M	−64%	Q2 2026
P/E	19.1	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.